Search

everythinglearnresearchcommunity

for

Search:↓

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

The tool to measure life quality for women with alopecia is reliable and accurate.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Low-dose minoxidil helps hair grow longer and thicker in people with short anagen syndrome.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Women with frontal fibrosing alopecia have similar vitamin D levels to those with other hair loss types, suggesting vitamin D is not a key factor in this condition.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Oral minoxidil may help improve fragile hair.

Personalized vitamin and trace element treatment improves hair density and reduces hair loss in men with early-stage androgenic alopecia.

Patients follow treatment well, but many change medicines; good information helps compliance.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Amino acid supplements may not be necessary for all women with chronic hair loss.

Low-dose oral minoxidil can cause serious heart complications.

Higher testosterone harms sperm motility, while higher estradiol improves sperm survival.

UV radiation increases protein loss from hair and reduces hair protein quality.

Breast cancer may be detectable through changes in scalp hair lipids.

Clascoterone safely promotes hair growth similar to minoxidil.

Copper deficiency is linked to post-COVID-19 hair loss in women.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.